Dechra Pharmaceuticals PLC — AGM Information 2013

Jul 29, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3851K

Dechra Pharmaceuticals PLC

29 July 2013

Dechra Pharmaceuticals PLC

("Dechra" or the "Company")

Result of General Meeting

Proposed disposal of the Services Segment

29 July 2013

For immediate release

At a General Meeting of the Company held earlier today, the resolution to approve the proposed disposal of the entire issued share capital of National Veterinary Services Limited to Patterson Companies, Inc. (the "Disposal"), as set out in the Notice of General Meeting dated 11 July 2013, was duly passed. The trade, assets and liabilities (save for certain excluded liabilities) of the Services Segment that were owned by Dechra Limited were transferred into National Veterinary Services Limited on 5 July 2013 in order to facilitate the Disposal.

Issued Share Capital at meeting date: 87,157,444

Number of Shareholders in attendance: 11

The resolution was passed on a show of hands

Details of the proxy voting instructions lodged prior to the General Meeting are set out below:  

Resolution	Votes for (1)	%	Votes against	%	Votes withheld(2)
To approve the proposed disposal of the entire issued share capital of National Veterinary Services Limited to Patterson Companies, Inc.	69,181,153	99.95	32,476	0.05	734,589

Notes

(1)   Includes discretionary votes

(2)   A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "For" and "Against" a resolution

(3)   No votes were lodged in favour of a Third Party

(4)   Votes tendered in respect of 69,213,629 shares representing 79.41% of the issued share capital

In accordance with Listing Rule 9.6.2, a copy of the resolution will shortly be submitted to the National Storage Mechanism and will be available for inspection at www.morningstar.co.uk/uk/NSM.

The full text of the resolution passed at the Meeting can be found in the Notice, which is available for inspection at www.morningstar.co.uk/uk/NSM and on the Company's website at www.dechra.com.

In addition to the passing of the above resolution, completion of the Disposal is conditional, inter alia, on the issue of certain regulatory licences in the name of National Veterinary Services Limited. The Company still expects the Disposal to complete by mid-August 2013.

Enquiries:
Zoe Goulding, Company Secretary	Fiona Tooley, Director
Dechra Pharmaceuticals PLC	TooleyStreet Communications
Telephone: + 44 (0) 1606 814730	Telephone: +44 (0) 121 309 0099
www.dechra.com	Mobile: +44 (0) 778 570 3523 (FT)
	Ticker: Full Listing (Pharmaceuticals): DPH

About Dechra

Dechra is an international veterinary pharmaceutical business.  Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

REGPGUAWMUPWGWB